188 related articles for article (PubMed ID: 8010321)
1. Stability of ondansetron hydrochloride in syrups compounded from tablets.
Williams CL; Sanders PL; Laizure SC; Stevens RC; Fox JL; Hak LJ
Am J Hosp Pharm; 1994 Mar; 51(6):806-9. PubMed ID: 8010321
[No Abstract] [Full Text] [Related]
2. Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration.
Pompilio FM; Fox JL; Inagaki K; Burm JP; Jhee S; Gill MA
Am J Hosp Pharm; 1994 Feb; 51(3):391-4. PubMed ID: 8160697
[No Abstract] [Full Text] [Related]
3. Stability of atenolol in an extemporaneously compounded oral liquid.
Garner SS; Wiest DB; Reynolds ER
Am J Hosp Pharm; 1994 Feb; 51(4):508-11. PubMed ID: 8017418
[TBL] [Abstract][Full Text] [Related]
4. Stability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4 degrees C.
Jhee SS; Jeong EW; Chin A; Inagaki K; Fox JL; Gill MA
Am J Hosp Pharm; 1993 Sep; 50(9):1918-20. PubMed ID: 8135242
[No Abstract] [Full Text] [Related]
5. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
McGuire TR; Narducci WA; Fox JL
Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
[TBL] [Abstract][Full Text] [Related]
6. Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration.
Burm JP; Jhee SS; Chin A; Moon YS; Jeong E; Nii L; Fox JL; Gill MA
Am J Hosp Pharm; 1994 May; 51(9):1201-4. PubMed ID: 7913797
[TBL] [Abstract][Full Text] [Related]
7. Compatibility of ondansetron hydrochloride with fluconazole, ceftazidime, aztreonam, and cefazolin sodium under simulated Y-site conditions.
Bosso JA; Prince RA; Fox JL
Am J Hosp Pharm; 1994 Feb; 51(3):389-91. PubMed ID: 8160696
[No Abstract] [Full Text] [Related]
8. Stability of ondansetron hydrochloride injection in extemporaneously prepared oral solutions.
Graham CL; Dukes GE; Fox JL; Kao CF; Hak LJ
Am J Hosp Pharm; 1993 Jan; 50(1):106-8. PubMed ID: 8427264
[TBL] [Abstract][Full Text] [Related]
9. Stability of hydralazine hydrochloride syrup compounded from tablets.
Alexander KS; Pudipeddi M; Parker GA
Am J Hosp Pharm; 1993 Apr; 50(4):683-6. PubMed ID: 8470684
[TBL] [Abstract][Full Text] [Related]
10. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
Sosnowska K; Winnicka K; Czajkowska-Kośnik A
Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
[TBL] [Abstract][Full Text] [Related]
11. Stability of propranolol hydrochloride suspension and solution compounded from injection or tablets.
Das Gupta V; Stewart KR
Am J Hosp Pharm; 1987 Feb; 44(2):360-1. PubMed ID: 3565399
[No Abstract] [Full Text] [Related]
12. Stability of procainamide hydrochloride syrups compounded from capsules.
Alexander KS; Pudipeddi M; Parker GA
Am J Hosp Pharm; 1993 Apr; 50(4):693-8. PubMed ID: 8470687
[TBL] [Abstract][Full Text] [Related]
13. Stability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bags.
Stewart JT; Warren FW; King DT; Venkateshwaran TG; Ponder GW; Fox JL
Am J Health Syst Pharm; 1997 Apr; 54(8):915-20. PubMed ID: 9114924
[No Abstract] [Full Text] [Related]
14. Pharmaceutical development of ondansetron tablets.
Leak RE; Woodford JD
Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S63-6. PubMed ID: 2533901
[TBL] [Abstract][Full Text] [Related]
15. Stability of famotidine in an extemporaneously prepared oral liquid.
Quercia RA; Jay GT; Fan C; Chow MS
Am J Hosp Pharm; 1993 Apr; 50(4):691-3. PubMed ID: 8470686
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
Zhang Y; Huang G; Yu Y; Han J; Yu P
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
[TBL] [Abstract][Full Text] [Related]
17. Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration.
Xu QA; Trissel LA; Fox JL
Ann Pharmacother; 1995 Nov; 29(11):1106-9. PubMed ID: 8573953
[TBL] [Abstract][Full Text] [Related]
18. Degradation of captopril in solutions compounded from tablets and standard powder.
Chan DS; Sato AK; Claybaugh JR
Am J Hosp Pharm; 1994 May; 51(9):1205-7. PubMed ID: 8042640
[No Abstract] [Full Text] [Related]
19. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Trissel LA; Tramonte SM; Grilley BJ
Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190
[No Abstract] [Full Text] [Related]
20. Effects of compounding and storage conditions on stability of pergolide mesylate.
Davis JL; Kirk LM; Davidson GS; Papich MG
J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
